ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 295 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $42,038 | -46.2% | 354 | -51.4% | 0.01% | -46.2% |
| Q1 2024 | $78,129 | +133.8% | 728 | +117.3% | 0.01% | +116.7% |
| Q4 2023 | $33,413 | -4.5% | 335 | +13.9% | 0.01% | -25.0% |
| Q3 2023 | $34,989 | -0.3% | 294 | +49.2% | 0.01% | -20.0% |
| Q2 2023 | $35,103 | +46.8% | 197 | +35.9% | 0.01% | +25.0% |
| Q1 2023 | $23,919 | +7.0% | 145 | +2.1% | 0.01% | +14.3% |
| Q4 2022 | $22,362 | +1.6% | 142 | -2.1% | 0.01% | -36.4% |
| Q3 2022 | $22,000 | -8.3% | 145 | -2.7% | 0.01% | -26.7% |
| Q2 2022 | $24,000 | -44.2% | 149 | -22.8% | 0.02% | -31.8% |
| Q1 2022 | $43,000 | +10.3% | 193 | +19.1% | 0.02% | +22.2% |
| Q4 2021 | $39,000 | +8.3% | 162 | +5.2% | 0.02% | -21.7% |
| Q3 2021 | $36,000 | -14.3% | 154 | -25.6% | 0.02% | -11.5% |
| Q2 2021 | $42,000 | +600.0% | 207 | +613.8% | 0.03% | +160.0% |
| Q1 2021 | $6,000 | – | 29 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 193,438 | $20,759,766 | 2.11% |
| Mesirow Institutional Investment Management, Inc. | 143,731 | $15,425,211 | 1.37% |
| SEGALL BRYANT & HAMILL, LLC | 484,635 | $52,011,028 | 0.98% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,534,742 | $164,708,506 | 0.72% |
| GAGNON SECURITIES LLC | 23,120 | $2,481,238 | 0.59% |
| KIRR MARBACH & CO LLC /IN/ | 22,540 | $2,418,993 | 0.58% |
| Wakefield Asset Management LLLP | 9,216 | $989,062 | 0.34% |
| Boston Trust Walden Corp | 341,090 | $36,605,779 | 0.26% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 278,436 | $29,881,752 | 0.20% |
| GW&K Investment Management, LLC | 165,991 | $17,814 | 0.16% |